Tina Cascone
0000-0003-3008-5407
Publication & Citation Trends
Publications
426 total
Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis
Cited by 1
Semantic Scholar
Perioperative nivolumab (NIVO) vs placebo (PBO) in patients (pts) with resectable NSCLC: Updated survival and biomarker analyses from CheckMate 77T.
Cited by 16
Semantic Scholar
138P: Outcomes by treatment (tx) cycles (cyc) with perioperative nivolumab (NIVO) in patients (pts) with resectable NSCLC from CheckMate 77 T study
Cited by 0
Semantic Scholar
LBA2 Clinical outcomes with perioperative nivolumab (NIVO) in patients (PTS) with resectable NSCLC from the phase III CheckMate 77T study OA
Cited by 5
Semantic Scholar
LBA50 Perioperative nivolumab (NIVO) v placebo (PBO) in patients (pts) with resectable NSCLC: Clinical update from the phase III CheckMate 77T study
Cited by 16
Semantic Scholar
121P Health-related quality of life (HRQoL) outcomes from CheckMate 77T: Neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) followed by adjuvant NIVO in resectable NSCLC OA
Cited by 1
Semantic Scholar
Perioperative Nivolumab in Resectable Lung Cancer.
Cited by 307
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(175)
Lung Cancer Treatments and Mutations
(138)
Lung Cancer Diagnosis and Treatment
(78)
Cancer Genomics and Diagnostics
(69)
Lung Cancer Research Studies
(42)
Affiliations
National Institutes of Health
Barnes-Jewish Hospital
The University of Texas MD Anderson Cancer Center
Central South University
Johns Hopkins University